| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/03/2007 | EP1658273B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 01/03/2007 | EP1569930B1 Indol derivatives and their use as 5-ht ligands |
| 01/03/2007 | EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/03/2007 | EP1389617B1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1890226A Oxazole derivatives of tetracyclines |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/03/2007 | CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 01/03/2007 | CN1889922A Use of osteopontin in dental formulations |
| 01/03/2007 | CN1889920A Microcapsules with uv filter activity and process for producing them |
| 01/03/2007 | CN1293077C Process for preparing 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one |
| 01/03/2007 | CN1293076C Activator for peroxisome proliferator-activated receptor delta |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/03/2007 | CN1292746C Pharmaceutical composition administered orally comprising amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and antioxidate |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157584 Benzimidazole derivative and use thereof |
| 01/02/2007 | US7157577 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors |
| 01/02/2007 | US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/02/2007 | US7157489 HIV protease inhibitors |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157482 Antibacterial 1,3-oxazolidin-2-one derivatives |
| 01/02/2007 | US7157476 Aminofurazan compounds useful as protein kinase inhibitors |
| 01/02/2007 | US7157473 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV) |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157460 Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 01/02/2007 | US7157455 4-Aminopyrimidine-5-one derivatives |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157453 Urea substituted imidazoquinolines |
| 01/02/2007 | CA2383409C Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 01/02/2007 | CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 12/28/2006 | WO2006138510A1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 12/28/2006 | WO2006138304A2 Pyrimidine compounds |
| 12/28/2006 | WO2006138259A2 Chemokine receptor binding compounds |
| 12/28/2006 | WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137790A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137706A1 6-(4-substituted-anilino)pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 12/28/2006 | WO2006137465A1 Nitrogenated heterocyclic derivative |
| 12/28/2006 | WO2006137421A1 Agent for topical administration |
| 12/28/2006 | WO2006136924A1 Histamine-3 receptor antagonists |
| 12/28/2006 | WO2006136821A1 Pharmaceutical compounds |
| 12/28/2006 | WO2006136553A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 12/28/2006 | WO2006136461A2 Non-steroidal progesterone receptor modulators |
| 12/28/2006 | WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | WO2006136245A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 12/28/2006 | WO2006136073A1 Herbicidal n-carboxyl substituted benzoxazine compounds |
| 12/28/2006 | WO2006122014A3 Bicyclic derivatives as modulators of ion channels |
| 12/28/2006 | WO2006103277A3 2 , 4 , 5-substituted piperidines as renin inhibitors |
| 12/28/2006 | WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 12/28/2006 | WO2005104711A3 Purification of progesterone receptor modulators |
| 12/28/2006 | WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/28/2006 | US20060293536 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 12/28/2006 | US20060293519 Method for producing cyclic diamine derivative or salt thereof |
| 12/28/2006 | US20060293339 Biaryl substituted 6-membered heterocycles as sodium channel blockers |
| 12/28/2006 | US20060293337 P2x7 receptor antagonists and their use |
| 12/28/2006 | US20060293336 C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293324 Pyrimidine compounds |
| 12/28/2006 | US20060293321 2-Heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel therapeutics in breast cancer |
| 12/28/2006 | US20060293320 Heteroaryl derivatives for treating viruses |
| 12/28/2006 | US20060293319 Oxindole derivatives |
| 12/28/2006 | US20060293318 Stereospecifically substituted benzo[1,3]dioxolyl derivatives |
| 12/28/2006 | US20060293315 Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation |
| 12/28/2006 | US20060293314 4- Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents |
| 12/28/2006 | US20060293313 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; shows high affinity for both the dopamine D2 receptor and the serotonin reuptake site, useful for treating central nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia |
| 12/28/2006 | US20060293310 Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme |
| 12/28/2006 | US20060293307 Oxazolidinone derivatives as antimicrobials |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | US20060293300 New substituted thiophene carboxamides, process for their preparation and their use as medicaments |
| 12/28/2006 | US20060293281 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 12/28/2006 | CA2612325A1 Chemokine receptor binding compounds |
| 12/28/2006 | CA2612227A1 Pyrimidine compounds |
| 12/28/2006 | CA2612133A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | CA2612105A1 Chemokine receptor binding compounds |
| 12/28/2006 | CA2611897A1 Non-steroidal progesterone receptor modulators |
| 12/28/2006 | CA2610742A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | CA2608929A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 12/28/2006 | CA2608319A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 12/27/2006 | EP1736474A1 Piperidine derivative |
| 12/27/2006 | EP1736472A1 2-aminopyridine derivative |
| 12/27/2006 | EP1736471A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
| 12/27/2006 | EP1736467A1 Novel sulfonamide derivative |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735307A1 Inhibitors of iap |
| 12/27/2006 | EP1735303A2 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof |
| 12/27/2006 | EP1735299A1 Tertrahydrobenzazepines as histamine h3 receptor ligands |
| 12/27/2006 | EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 12/27/2006 | EP1735288A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1735284A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides |
| 12/27/2006 | EP1735282A1 Pyrazole compounds and uses related thereto |
| 12/27/2006 | EP1735278A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 12/27/2006 | EP1735270A1 Diamino alcohols and their use as renin inhibitors |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |